Cohance Lifesciences Ltd. NSE: COHANCE | BSE: 543064

Expensive Underperformer

629.10 -60.80 (-8.81%)

5.9M

NSE+BSE Volume

NSE 13 Nov, 2025 3:31 PM (IST)

Margin Decline

Cohance's Q2FY26 net profit dips 51% YoY; EBITDA margin down 12.6% on investment, integration costs See details

Cohance Lifesciences Ltd. Shareholding Pattern for - Promoter, FII, DII, Mutual Fund holding

Cohance Lifesciences Ltd. shareholding pattern - Promoter holding and pledges, FII, DII, Mutual Fund holding change for the quarter.

Quarter Ending

Summary	Sep 2025	Jun 2025	May 09, 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Promoter	57.5%	66.4%	66.4%	50.1%	50.1%	50.1%	50.1%	50.1%	60%	60%	60%	60%
Holding	57.5%	66.4%	66.4%	50.1%	50.1%	50.1%	50.1%	50.1%	60%	60%	60%	60%
Pledged	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Locked	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
FII	6.5%	7.2%	7.4%	11.1%	10.8%	10.7%	9.8%	9.5%	10.1%	10.0%	9.5%	9.5%
DII	20.8%	11.4%	11.0%	16.6%	16.7%	17.0%	17.4%	17.3%	16.0%	14.1%	10.6%	11.4%
Mutual Funds	16.49%	8.90%	8.65%	13.04%	13.15%	14.12%	14.78%	15.26%	13.40%	12.15%	9.12%	8.56%
Banks	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Insurance	3.95%	2.27%	2.17%	3.26%	3.20%	2.53%	2.09%	1.57%	1.89%	1.38%	0.11%	2.26%
Others	0.38%	0.24%	0.21%	0.31%	0.33%	0.31%	0.56%	0.42%	0.66%	0.61%	1.41%	0.61%
Public	15.2%	15.0%	15.2%	22.2%	22.4%	22.3%	22.7%	23.1%	13.9%	15.9%	19.9%	19.1%
Others	0.0%	0%	0%	0%	0.0%	0%	0%	0%	0%	0%	0%	0%